Related Experiment Video
Updated: Dec 24, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
Evolving functions of Dickkopf-1 in cancer and immunity
Nikolai Jaschke1, Lorenz C Hofbauer2, Andy Göbel2
1Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Center for Healthy Ageing, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, Austria.
Abstract:
Dickkopf-1 (DKK-1) is a well-established inhibitor of canonical Wnt-signaling that critically participates in the regulation of bone formation and has been implicated in the development and progression of bone metastases. While the skeleton was originally considered the sole site of DKK-1 synthesis, it has now become clear that the molecule is also highly expressed in T-cells, platelets and multiple cancer cells. In the past years, several new functions of DKK-1 in angiogenesis, cancer cell biology, immune homeostasis and inflammation have been revealed. These novel insights have paved the way for clinical trials investigating the efficacy of anti-DKK-1 antibodies in a variety of different malignancies, most of which are currently still ongoing. In this review, we discuss the evolution and recent advances in DKK-1 research and highlight clinical implications of the available knowledge on the molecule, especially in cancer. Finally, we emphasize outstanding questions and provide an outlook on potential future studies that will aid in further improving our understanding of the pleiotropic roles of DKK-1 in health and disease.
Insights
Dickkopf-1 (DKK-1), a Wnt-signaling inhibitor, is crucial in bone formation and cancer. Emerging research reveals its roles in angiogenesis and immunity, leading to clinical trials for anti-DKK-1 therapies in malignancies.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Background:
- Dickkopf-1 (DKK-1) is a key inhibitor of Wnt signaling, vital for bone formation.
- Initially thought to be synthesized only in bone, DKK-1 is now known to be expressed in T-cells, platelets, and cancer cells.
Purpose of the Study:
- To review the evolving understanding of DKK-1 functions beyond bone regulation.
- To highlight the clinical implications of DKK-1 research, particularly in oncology.
- To identify future research directions for DKK-1 in health and disease.
Main Methods:
- Literature review of DKK-1 research.
- Analysis of DKK-1's roles in angiogenesis, cancer biology, immune homeostasis, and inflammation.
- Examination of ongoing clinical trials involving anti-DKK-1 antibodies.
Main Results:
- DKK-1 plays significant roles in angiogenesis, cancer cell proliferation, and immune regulation.
- Clinical trials are investigating anti-DKK-1 antibodies for various cancers.
- DKK-1's pleiotropic functions are increasingly recognized.
Conclusions:
- DKK-1 is a multifaceted molecule with implications beyond bone metabolism, especially in cancer.
- Targeting DKK-1 presents a promising therapeutic strategy for malignancies.
- Further research is needed to fully elucidate DKK-1's complex roles and optimize therapeutic applications.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Canonical Wnt Signaling Pathway

